NASDAQ:AUXL - Auxilium Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$36.47 0.00 (0.00 %)
(As of 07/22/2018 02:32 PM ET)
Previous Close$36.47
Today's RangeN/A
52-Week Range$17.10 - $37.92
VolumeN/A
Average Volume1.32 million shs
Market Capitalization$1.85 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.66
Auxilium Pharmaceuticals logoAuxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in men's healthcare. The company's products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.

Receive AUXL News and Ratings via Email

Sign-up to receive the latest news and ratings for AUXL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNASDAQ:AUXL
CUSIP05334D10
Phone+1-484-3215900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-29.78%
Return on Equity-76.75%
Return on Assets-11.59%

Miscellaneous

EmployeesN/A
Outstanding Shares51,020,000
Market Cap$1,850.00

Auxilium Pharmaceuticals (NASDAQ:AUXL) Frequently Asked Questions

What is Auxilium Pharmaceuticals' stock symbol?

Auxilium Pharmaceuticals trades on the NASDAQ under the ticker symbol "AUXL."

How were Auxilium Pharmaceuticals' earnings last quarter?

Auxilium Pharmaceuticals Inc (NASDAQ:AUXL) posted its quarterly earnings data on Thursday, October, 30th. The biopharmaceutical company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.30. The biopharmaceutical company earned $109.60 million during the quarter, compared to analysts' expectations of $101.02 million. Auxilium Pharmaceuticals had a negative return on equity of 76.75% and a negative net margin of 29.78%. The firm's quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.17 EPS. View Auxilium Pharmaceuticals' Earnings History.

What is the consensus analysts' recommendation for Auxilium Pharmaceuticals?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Auxilium Pharmaceuticals in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Auxilium Pharmaceuticals been receiving favorable news coverage?

Headlines about AUXL stock have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Auxilium Pharmaceuticals earned a media sentiment score of 0.04 on Accern's scale. They also assigned news headlines about the biopharmaceutical company an impact score of 45.72 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Auxilium Pharmaceuticals?

Shares of AUXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Auxilium Pharmaceuticals' stock price today?

One share of AUXL stock can currently be purchased for approximately $36.47.

How big of a company is Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals has a market capitalization of $1.85 billion.

How can I contact Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals' mailing address is 640 Lee Rd, CHESTERBROOK, PA 19087-5636, United States. The biopharmaceutical company can be reached via phone at +1-484-3215900.


MarketBeat Community Rating for Auxilium Pharmaceuticals (NASDAQ AUXL)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  232 (Vote Outperform)
Underperform Votes:  174 (Vote Underperform)
Total Votes:  406
MarketBeat's community ratings are surveys of what our community members think about Auxilium Pharmaceuticals and other stocks. Vote "Outperform" if you believe AUXL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AUXL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.